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Abstract
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Clinical studies suggest cardiovascular and renal benefits of ingesting small amounts of ethanol.
Effects of ethanol, role of alcohol dehydrogenase (ADH) or of 20-hydroxyeicosatetraenoic acid
(20-HETE) in podocytes of the glomerular filtration barrier have not been reported. We found that
mouse podocytes at baseline generate 20-HETE and express ADH but not CYP2e1. Ethanol at
high concentrations altered the actin cytoskeleton, induced CYP2e1, increased superoxide
production and inhibited ADH gene expression. Ethanol at low concentrations upregulated the
expression of ADH and CYP4a12a. 20-HETE, an arachidonic acid metabolite generated by
CYP4a12a, blocked the ethanol-induced cytoskeletal derangement and superoxide generation.
Ethanol at high concentration or ADH inhibitor increased glomerular albumin permeability in
vitro. 20-HETE and its metabolite produced by ADH activity, 20-carboxy-arachidonic acid,
protected the glomerular permeability barrier against an ADH inhibitor, puromycin or FSGS
permeability factor. We conclude that ADH activity is required for glomerular function, 20-HETE
is a physiological substrate of ADH in podocytes and that podocytes are useful biosensors to
understand glomeruloprotective effects of ethanol.
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1. Introduction
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The effect of ethanol on human behavior and metabolism with its psychosocial and
economic implications has been widely studied. Negative effects of excessive ethanol
consumption include injury to brain and liver tissues as well as exacerbation of hypertension
and cardiovascular disease [1]. In contrast, ingestion of moderate amounts of ethanol in the
form of alcoholic beverages has been associated with improved cardiovascular survival and
other health benefits [2, 3]. A recent review suggests that small amounts of ethanol may
lower the risk of kidney disease and may have clinically beneficial effect on renal function
and the progression of chronic kidney disease [4]. Potential renoprotection by small amounts
of ethanol indicate its role in glomerular function. However, the mechanism of dosedependent switch in its effect from toxic to beneficial is not clear.
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Ethanol at high concentrations injures cells by direct toxicity, through its metabolites and
oxidative stress. Ethanol is mainly metabolized by two pathways namely, alcohol
dehydrogenase (ADH) and cytochrome P4502E1 (human CYP2E1, mouse CYP2e1). ADH
oxidizes ethanol to aldehyde in an NAD+-dependent reaction followed by transport of
aldehyde to mitochondria where it is converted into acetate by aldehyde dehydrogenase. In
another reaction CYP2E1, the main enzyme of the microsomal ethanol oxidation system,
converts ethanol into acetaldehyde with production of free radicals leading to oxidative
stress in a NADPH-dependent reaction. Thus, the metabolic fate of ethanol depends on its
concentration in the target cells.
Effects of ethanol ingestion on the kidney and specifically on podocytes (glomerular visceral
epithelial cells) responsible for maintaining the filtration barrier have not been reported.
Podocytes are terminally differentiated cells that control the glomerular macromolecular
permeability barrier function and determine the passage of proteins into urine. They are
characterized by a unique actin cytoskeleton, interdigitating foot processes and specialized
intercellular slit-junctions [5]. Derangement of the actin cytoskeleton, foot process fusion
and loss of slit-junctions are associated with glomerular dysfunction, and precede
proteinuria [6].

Author Manuscript

Proteinuria is associated with chronic kidney disease (CKD) and is an independent indicator
of cardiovascular disease [7]. Patients with systemic diseases including hypertension and
diabetes mellitus often develop CKD progressing to end-stage renal disease (ESRD). Thus,
changes in podocyte structure and the resulting alteration in glomerular filtration barrier
function are early events in the progressive loss of glomerular function, onset of proteinuria
and chronic disease. Due to its wide-ranging effects, ethanol may positively and negatively
affect several metabolites and signaling pathways involved in regulating glomerular barrier
function.
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Arachidonic acid is converted to 20-hydroxyeicosatetraeneoic acid (20-HETE) by
cytochrome P450 (CYP450) 4A omega hydroxylases. We have found that 20-HETE is
required for maintaining the glomerular permeability barrier function. 20-HETE also
protects the glomerular filtration barrier from a circulating factor in the plasma from patients
with recurrent focal segmental glomerulosclerosis (FSGS permeability factor), a progressive
glomerular disease that leads to ESRD [8]. Similarly, 20-HETE protects against glomerular
injury caused by puromycin aminonucleoside-induced nephrosis in a model of minimal
change disease [9]. Since podocytes provide most of the resistance to passage of plasma
proteins through the glomerular filtration barrier, the glomeruloprotective effect of 20-HETE
may well originate from podocytes. The omega-OH group in 20-HETE is the molecular site
for ADH catalytic activity. Indeed, it has been shown that 20-HETE is oxidized by ADH to
form 20-carboxy (COOH)-arachidonic acid (AA) [10].
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We studied selected aspects of the effects of low and high concentrations of ethanol (0.02–
0.4 mmol/mL) on immortalized mouse podocytes and isolated rat glomeruli. Results
summarized here show that high concentrations of ethanol induce CYP2e1, cause oxidative
stress and alter the actin cytoskeleton, downregulate ADH protein and CYP4a12a gene in
mouse podocytes. In contrast, low concentrations of ethanol upregulate ADH and CYP4a12a
expression, and do not derange the actin cytoskeleton. Inhibition of ADH resulted in
increased glomerular albumin permeability similar to that caused by PAN or FSGS
permeability factor. 20-HETE or its metabolite 20-COOH-AA blocked the increase in
glomerular permeability. Our results suggest the possibility that 20-HETE is a physiological
substrate of ADH activity in glomerular podocytes and that very small amounts of ethanol
protect the glomerular filtration barrier, an effect that is reversed by higher amounts of
ethanol.
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2. Methods
2.1. Animals and Institutional Approvals
These studies were carried out using protocols approved by the Institutional Animal Care
and Use Committee (IACUC) at the Kansas University Medical Center, Kansas City, KS,
USA and by the IACUC, Safety Subcommittee and the Research and Development
Committee at the VA Medical Center, Kansas City, MO, USA. Animals were obtained from
national vendors and maintained at the Animal Resource Facility under control temperature,
humidity and a light/dark cycle of 12/12 hr with unrestricted access to standard diet and
water. ARF is approved by the Association for Assessment and Accreditation of Laboratory
Animal Care (AAALAC) International.
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2.2. Cell culture
Immortalized mouse podocytes with thermosensitive tsA58 mutant T-antigen were grown
on collagen in 75 cm2 flasks, plastic petri dishes, glass coverslips or multiwell plates.
Medium consisted of RPMI 1640 (Mediatech, Manassas, VA) with L-glutamine
supplemented with 10% fetal bovine serum, interferon-γ (IFN-γ), 100 units/mL penicillin
and 0.1 mg/mL streptomycin with 5% CO2 and 95% humidity in the atmosphere. Cells
grown to 80% confluence in medium containing mouse interferon-γ at 33°C were divided
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and grown at 37°C in the same medium without IFN-γ to differentiate and used on day 14
[11].
2.3. Treatment of cells with ethanol
Differentiated podocytes were treated with 1, 2, 5, 10, and 20 μL/mL (v/v) ethanol
(approximately 0.02–0.4 mmol/mL, 20–400 mM) in the culture medium and incubated for
1–24 hr at 37°C. Time-matched control cells were treated with equivalent volumes of the
medium. Molecular biology grade ethanol (Sigma-Aldrich) was used. ADH inhibitor
fomepizole (4-methylpyrazole, Sigma-Aldrich, St Louis, MO), 20-hydroxyeicosatetraenoic
acid (20-HETE, Cayman Chemical, Ann Arbor, MI) or 20-carboxy-arachidonic acid (20COOH-AA, Cayman Chemical) were used in some experiments.
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2.4. Visualization of ethanol-induced changes in the actin cytoskeleton using confocal
microscopy
Podocytes grown on coverslips were incubated with ethanol for 8 hr, fixed in 4%
paraformaldehyde, permeabilized and incubated with Alexa Fluor 568 Phalloidin (1:200) for
30 minutes in the dark and washed with PBS. The coverslips mounted were viewed using a
Carl Zeiss LSM 510 confocal microscope (63x) with laser at 543 nm. Laser intensity, gain
settings, scaling, individual section depth, and pinhole settings were kept constant.
2.5. Determination of ethanol-induced apoptotic changes using flow cytometry

Author Manuscript

Podocytes were analyzed using flow cytometry to determine apoptotic changes at 6 and 24
hr after incubation with ethanol (0.2 or 0.4 mmol/mL). For each experimental group, 1–5 ×
105 cells were collected by centrifugation and resuspended in 500 μL of 1X Annexin V
Binding Buffer. Annexin V-FITC 5 μL and propodium iodide 5 μL (Life Technologies)
were added and each group incubated for 10 minutes at room temperature, and injected into
a BD LSR II flow cytometer at KU Medical Center, Kansas City, KS and data were
analyzed using FlowJo software.
2.6. Gene expression studies using Quantitative RT-PCR (RT-qPCR)
Podocytes incubated with ethanol (0.2 or 0.4 mmol/mL) were analyzed for CYP2e1 at 4 hr
in parallel with determination of cellular superoxide at 4 hr when superoxide production due
to 0.2 and 0.4 mmol/mL ethanol was noticeable. Podocytes were incubated with ethanol
(0.02–0.4 mmol/mL) for 1, 8 and 24 hr to study CYP4a12a gene expression at early to late
time points in these experiments.
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TRI Reagent (Molecular Research Center, Cincinnati, OH) and RNase-free DNase (Qiagen,
Valencia, CA) were used to isolate total RNA and to remove DNA, respectively. First-strand
cDNA was synthesized using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Total
RNA (1 μg, 20 μL) was reverse transcribed followed by RT-qPCR using 100 ng of total
RNA in each reaction. The iCycler iQ Real-Time PCR Detection System and iQ SYBR
Green Supermix (Bio-Rad) were used for quantitative RT-PCR analysis. The relative gene
expression was expressed using cycle threshold (Ct) values of the gene of interest
normalized with GAPDH in the same sample. The sequences of primers used in the real–
time PCR analyses of various genes are:
Prostaglandins Other Lipid Mediat. Author manuscript; available in PMC 2016 January 01.
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CYP2e1

Forward: GCTGCCCATCATTATCCCTTAC
Reverse: TCTTACCCACTGAGCCATCT

GAPDH

Forward: GCCTTCCGTGTTCCTACCC
Reverse: TGCCTGCTTCACCACCTTC

2.7. 20-HETE quantitation using Liquid Chromatography-Mass Spectrometry (LC-MS)
analysis

Author Manuscript

Differentiated podocytes were used for determination of 20-HETE levels using established
protocols at the Mass Spectrometry Facility, Department of Pharmacology, Medical College
of Wisconsin, Milwaukee, WI [12, 13]. Liquid chromatography-electrospray ionizationmass spectrometry (Agilent 1100 LC-MSD, SL model) was used for chromatography on
C18 column (Kromasil 100, 250×2.0 mm, 5μm, Phenomenex, Torrance, CA) using a
gradient of water (solvent A) and acetonitrile (solvent B) with 0.005% acetic acid as the
mobile phase (200 μl/min). Mass spectrometry detection was carried out in negative mode
and analytes were quantitated comparing the ratios of peak areas (compounds/internal
standards) to the standard curves and expressed as pg/mg protein.
2.8. Western Blot analysis for protein expression and phosphorylation
Podocytes were incubated with ethanol (0.02–0.4 mmol/mL) for one hr to determine
changes at the earliest time point in these experiments. Change in total ADH protein levels
and phosphorylation of Akt and/or ERK1/2 were determined.
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ADH protein expression Akt and ERK1/2 phosphorylation were analyzed in cell lysates by
SDS-PAGE using TGX gels (BioRad) followed by electro-transfer to PVDF membranes and
detection using specific antibodies in TBST containing5% dry milk as the blocking agent. βactin was used as loading control. Primary antibodies included anti-ADH antibody (1:200
dilution) from Abcam, (Cambridge, MA). Anti-phosphoERK (1:2000 dilution), anti-total
ERK (1:5000 dilution), anti-phosphoAkt (1:2000), anti-total Akt (1:1000) were obtained
from Cell Signaling Technology, Danvers, MA. Anti-β actin (1:10,000 dilution) and
peroxidase conjugated secondary antibodies (1:5000) were used (Sigma-Aldrich, St. Louis,
MO). ECL (GE Healthcare, Piscataway, NJ) was used for visualizing and images were
recorded using Kodak Gel Logic 2200 imaging system (Carestream Health Inc, New Haven,
CT).
2.9. Fluorescence microscopy to assay superoxide generation
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Podocytes on glass coverslips were incubated with ethanol (EtOH) 0.2 mmol/mL and 0.4
mmol/mL for 1 or 4 hr at 37°C. After washing with HEPES buffer cells were incubated with
dihydroethidium (HE, 15μM) for 15 min, mounted on microscope slides with 5% npropylgallate 9:1 glycerol:PBS and observed using a Leica microscope (excitation-550 nm
and emission-650 nm). Fifteen to twenty cells were observed in each group in 2 separate
experiments and fluorescence intensities were quantified using the microscope software.
Results are presented as change in fluorescence (fold increase) compared to vehicle-treated
control group expressed as 1.
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Details of the method have been described [14]. Briefly, fresh preparations of glomeruli
isolated from Sprague Dawley rats (200–250 g) were suspended in modified Ringer’s
solution containing 5% BSA. Glomeruli were incubated with control or test agent (final
volume 1 mL) for 15 minutes at 37°C. Five glomeruli from one rat were observed
individually using videomicroscopy. First set of images was obtained with 5% BSA in the
bath medium. A second image of each glomerulus was obtained after changing the bath
medium to 1% BSA to generate an oncotic gradient. Images were analyzed for change in
glomerular volume following change of medium by morphometry. The ratio of ΔV of
experimental to ΔV of control glomeruli in response to identical oncotic gradients was used
to calculate Reflection coefficient (σalb) = ΔVexperimental/ΔVcontrol. Convectional
permeability to albumin (Palb): (1−σalb) describes the movement of albumin consequent to
water flow. When σalb is zero, albumin moves at the same rate as water and Palb is 1.0.
When σalb is 1.0, albumin cannot cross the membrane with water and Palb is zero.
2.11. Statistical analyses
Descriptive statistics such as means and proportions were used. Mean values were compared
using Student’s t-test and P<0.05 was accepted as significant.

3. Results
3.1. Ethanol altered the actin cytoskeleton of cultured podocytes

Author Manuscript

Control and cells treated with lower concentrations of ethanol (0.02 or 0.1 mmol/mL)
showed linear and parallel arrangement of thick actin filament bundles. The actin
cytoskeleton underwent changes at higher concentrations of ethanol (0.2 or 0.4 mmol/mL).
The linear and parallel pattern was lost, and the thin bundles of short actin filaments
acquired mesh-like random orientation. Pre-treatment with 100 nM 20-HETE prevented the
formation of actin bundles (Fig. 1).
3.2. Flow cytometry analysis of ethanol-treated cells
We followed the microscopy observations by flow cytometry to determine apoptotic
changes caused by ethanol. Figure 2 shows the effect of ethanol 0.2 and 0.4 mmol/mL at 6
and 24 hr. At 6 hr, normal cells constituted approximately 80% of the total in control and
ethanol-treated (0.2 and 0.4 mmol/mL) groups. However, the abundance of normal cells
decreased by 20% at 24 hr in both ethanol-treated groups compared to the control group.

Author Manuscript

Early apoptotic cells in the 0.2 mmol ethanol/mL group were 79% and 16% higher than the
control group at 6 and 24 hr, respectively. Cells showing early apoptosis in the 0.4 mmol
ethanol group were 13% higher and 25% lower than the control group at 6 and 24 hr,
respectively.
The abundance of cells undergoing Late apoptosis+necrosis increased by 69% and 23% in
the ethanol-treated groups (0.2 and 0.4 mmol/mL), respectively, by 24 hr.
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Although we did not determine cytotoxicity of different concentrations of ethanol in parallel
experiments, these data suggest that ethanol 0.4 mmol/mL caused cell death and therefore
we did not observe a gradual increase in apoptotic cell. Thus, ethanol at 0.1–0.2 mmol/mL
concentrations would be optimum concentrations to study the chronicity of cellular changes
in future experiments.
3.3. Normal podocytes synthesize 20-HETE
We have previously shown that 20-HETE preserves and protects the glomerular filtration
barrier [9]. LC-MS results demonstrate that 20-HETE is present in normal untreated
podocytes. Briefly, the concentration of 20-HETE was 530.9±50.4 pg/mg protein compared
to 19-HETE at 236.2±5.3 pg/mg protein (mean±SD, n=4 biological replicates each). Thus,
20-HETE is formed in podocytes under basal physiological conditions.
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3.4. Ethanol at high concentrations increases superoxide generation in podocytes and
induces the expression of superoxide producing cytochrome P450 2e1 in podocytes
High concentrations of ethanol significantly increased superoxide production in podocytes
and thereby oxidative stress as shown using dihydroethidium (HE) (Figure 3A, 3B and 3C).
CYP2e1 plays an important role in ethanol metabolism, particularly in settings of high
concentrations and/or chronic exposure to alcohol. Ethanol metabolism by CYP2e1 causes
production of superoxide. The presence of CYP2e1 in podocytes has not been previously
described.
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Ethanol at 0.2 or 0.4 mmol/mL caused significant increase in superoxide production at 1, 4
and 24 hr (P<0.05, Figure 3A). At 1 hr, superoxide production caused by 0.2 mmol/mL
ethanol was lower (P<0.05) than that caused by 0.4 mmol/mL, comparable superoxide
production was observed at 4 and 24 hr (Figure 3A). Pre-treatment of cells with 100 nM 20HETE for 15 minutes blocked the effect of ethanol 0.2 or 0.4 mmol/mL (Figure 3B, 3C). To
determine whether ethanol at high concentrations induces expression of CYP2e1 in parallel
with increased superoxide production, podocytes were incubated with ethanol 0.2 and 0.4
mmol/mL for 4 hr, and expression of CYP2e1 was examined using RT-qPCR. As shown in
Figure 3D, ethanol (0.4 mmol/mL) markedly increased the expression of CYP2e1 at 4 hr
(P<0.001 vs. control).
3.5. High concentration of ethanol down regulates CYP4a12a gene expression at 24 hr
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Since 20-HETE protects the glomerular barrier function, we determined the effect of ethanol
on CYP4a12a omega hydroxylase gene expression. Podocytes were incubated with ethanol
at various concentrations (0.02, 0.04, 0.1, 0.2 and 0.4 mmol/mL). Results are shown in
Figure 4. Ethanol at 0.02, 0.04, 0.1, 0.2 mmol/mL caused significant increase in the
expression of CYP4a12a at 8 hr (P<0.05 compared to control). However, by 24 hr, ethanol
0.4 mmol/mL caused decreased expression of CYP4a12a (P<0.05 compared to control).
Thus, any beneficial effect of ethanol may only be at low concentrations since higher
amounts down regulated CYP4a12a gene expression by 24 hr. This finding also suggest that
CYP4a12a is expressed in podocytes which corresponds with the presence of 20-HETE
detected in untreated podocytes.
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3.6. Podocytes express ADH and ethanol causes a dose-dependent effect on total ADH
protein
We next determined the effect of ethanol on the alternative pathway for alcohol metabolism
that does not result in superoxide production. Ethanol (0.04–0.1 mmol/mL for 1 hr) caused a
dose-dependent increase in ADH protein in cultured podocytes (P<0.05 vs. control, Figure
5A and 5B) followed by a decrease at the highest concentration of ethanol tested (0.4 mmol/
mL). These data suggest a rapid effect of ethanol on ADH protein in podocytes.
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We selected changes in Akt and ERK phosphorylation as representative molecules of
pathways that ethanol is known to modulate. Akt is a key enzyme in cell survival and
regulates a number of interconnected signaling molecules. Ethanol at 0.02 and 0.04
mmol/mL showed a trend towards decreasing pAkt that did not reach statistical significance
(Figure 5D). In contrast, higher concentrations of ethanol (0.1–0.4 mmol/mL) significantly
increased pAkt in cultured podocytes (P<0.05 compared to control, Figure 5C, 5D).
Ethanol is known to alter several signaling pathways and its effect on MAPK pathways may
show cell-specificity. Intensity ratios for pERK1/2 (protein/β-actin) increased significantly
at ethanol concentrations 0.1, 0.2 and 0.4 mmol/mL (P<0.05) (Figure 5E, 5F).
3.7. Ethanol causes dual changes in glomerular albumin permeability (Palb) in vitro
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The effect of ethanol at low or high concentrations on glomerular filtration barrier is not
known. We determined the effect of ethanol on Palb using isolated glomeruli. Glomeruli
were incubated with ethanol (0.04–0.4 mmol/mL) in the incubation medium. Control
glomeruli were incubated in the medium without ethanol. Glomeruli treated with ethanol 0.4
and 0.1 mmol/mL showed Palb values lower than the control (P<0.001 and P<0.05,
respectively, Figure 6A). Ethanol at 0.4 mmol/mL significantly increased Palb (P<0.001),
while 0.2 mmol/mL did not alter Palb significantly. In some experiments we determined the
effect of ADH inhibitor fomepizole on Palb in glomeruli treated with ethanol 0.04 or 0.1
mmol/mL. Results (Figure 6B) show that pre-treatment with fomepizole blocked the effect
of 0.04 or 0.1 mmol ethanol and caused an increase in Palb (P<0.001 vs. ethanol 0.04 or 0.1
mmol).
3.8. ADH inhibitor fomepizole increases Palb and 20-HETE blocks this effect
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Detection of ADH in podocytes and its response to ethanol suggests a possible role of this
enzyme activity in glomerular barrier function. We studied the effect of ADH inhibition
with fomepizole on Palb in vitro. Fomepizole (2–10 μM) increased Palb in a dose-dependent
manner (P<0.001 compared to control, Figure 7A). Pre-treatment of glomeruli with 20HETE (0.1 μM) for 15 minutes blocked the increase in Palb caused by fomepizole. However,
adding 20-HETE to glomerular suspension 5 minute after fomepizole did not block the
increase in Palb (Figure 7B). These results suggest that ADH and 20-HETE are required for
glomerular protein permeability barrier function.
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3.9. 20-HETE and its metabolite 20-COOHarachidonic acid block the effect of FSGS factor
or PAN on glomerular albumin permeability
ADH metabolizes 20-HETE to 20-carboxy (COOH)-arachidonic acid (AA) by converting
the C20 omega-hydroxyl group to carboxyl group (Figure 8A). C20-COOH-AA is an
intracellular metabolite of 20-HETE that activates PPAR-α and PPAR-γ [10].
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Figure 8B shows the results of treating isolated glomeruli with 20-HETE (0.1 μM), 20COOH-AA (0.1, 1 μM) followed by FSGS serum (20 μL/mL) or by PAN (20 μg/mL).
Change in Palb was determined using an in vitro assay. 20-HETE or 20-COOH-AA did not
alter glomerular permeability. FSGS increased albumin permeability (P<0.001) and its effect
was blocked by 20-HETE (0.1 μM) or 20-COOH-AA (0.1 μM) (Figure 8B). Incubation of
glomeruli with PAN also increased albumin permeability (P<0.001). 20-HETE (0.1 μM) or
20-COOH-AA (1 μM) blocked the increase in permeability caused by PAN (Figure 8C).
Thus, both 20-HETE and its ADH metabolite protect the glomerular barrier function from
injury. ADH may be involved in converting 20-HETE to 20-COOH-AA to maintain
glomerular barrier function under physiological conditions.

4. Discussion
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This report contains several novel observations regarding the effect of ethanol on podocyte
structure and function. Ethanol showed dual effects on podocytes. At low concentrations,
ethanol upregulated the expression of ADH and CYP4A isoforms. Others have shown that
ADH can metabolize 20-HETE to 20-COOH-AA. We show here that untreated podocytes
generate 20-HETE that may be a substrate for ADH under basal conditions in the absence of
ethanol. ADH is known to metabolize 20-HETE to 20-COOH-AA and we show that 20COOH-AA protects glomerular barrier function similar to the protective effect of 20-HETE.
At higher concentrations, ethanol induced the expression of CYP2e1, increased superoxide
production and altered cytoskeleton and glomerular function. We hypothesize that these
events overcome protection afforded by lower concentrations of ethanol. These results are
consistent with the clinical observation that moderate intake of alcoholic beverages may
have health benefits. Our findings raise the intriguing possibility that low to moderate
alcohol intake increases the synthesis of the salutary eicosanoids 20-HETE and 20-COOHAA in the glomerulus and that these metabolites contribute to the health benefits of
moderate ethanol use.
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The effect of alcohol consumption on kidney function in health and disease is not clear.
Alcohol can damage the kidney directly [19–21] or through hypertension that is induced or
exacerbated by alcohol consumption [21]. Consumption of more than moderate amounts of
alcohol is associated with increased risk of renal failure [21, 22]. Alcohol consumption is an
independent risk factor for renal failure following liver transplantation [23]. Chronic alcohol
abuse in humans has been linked to tubular dysfunction and necrosis, IgA nephropathy as
well as renal structural and functional abnormalities in the fetal alcohol syndrome [20].
Prenatal exposure to alcohol reduces nephron number and increases glomerular volume [24].
In contrast, moderate alcohol consumption may reduce the risk for cardiovascular disease
and diabetes [25, 26] and thus protect against kidney disease. In addition to a secondary
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protective effect, i.e. lower risk of cardiovascular disease and diabetes and therefore less
kidney disease, moderate alcohol consumption may have other effects. Moderate alcohol
consumption is associated with decreased risk of myocardial infarction irrespective of the
type of beverage, i.e. beverages other than red wine also appear to confer benefit [27]. Thus,
there is growing recognition that moderate alcohol consumption may have a beneficial effect
on the development and progression of CKD [4].
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CKD associated with diabetes and hypertension is characterized by a gradual loss of
glomerular function and increase in urinary protein excretion. These pathophysiological
changes directly relate to the early changes in glomerular cells. Podocytes constitute the
main cellular barrier to regulate the passage of plasma macromolecules into glomerular
filtrate. Derangement of podocyte cytoskeleton and foot process fusion are important
clinical indicators of glomerular dysfunction that precede the onset of proteinuria [28, 29].
Podocytes are the principal site of glomerular damage in familial and idiopathic forms of
focal segmental glomerulosclerosis (FSGS) and in puromycin aminonucleoside (PAN)
induced nephrosis model of minimal change disease. Circulating factor(s) in idiopathic
FSGS target podocytes to increase glomerular albumin permeability prior to the onset of
albuminuria [8, 30]. We use cell culture and glomerular models to study the
pathophysiology of the glomerulus.
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Effects of ethanol on the structure and function of glomerular cells are not known. Ethanol
alters the expression of a large number of genes involved in several cellular processes
including stress response, protein modification, gene regulation, cell signaling and ethanol
metabolism itself [31]. Effects of ethanol in humans are determined by a number of factors
including genetic background, gender, body fat, age, quantity, and the rate and frequency of
alcohol consumption [32]. The legal limit of blood alcohol in the USA is 0.08%. We used
ethanol at concentrations covering a wide range that would correspond to moderate drinking
to high amounts of ethanol consumed during binge drinking that may be fatal.
Concentrations used were 0.1% to 2% (v/v) or 0.086–1.72% (w/v) equivalent to
approximately ethanol 0.02–0.4 mmol/mL (20–400 mM) medium. Also, published studies
indicate that response to identical concentration of ethanol varies with the cell type [33].
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We found that the concentration of ethanol determines its metabolic route in podocytes.
CYP2E1 takes on greater importance in ethanol oxidation in settings of high concentrations
of ethanol. CYP2E1 generates superoxide [34, 35] and oxidizes drugs [36]. CYP2E1
expression is induced in diabetes, starvation and obesity [37]. Normal glomeruli do not
express CYP2E1 [32] but proximal tubule cells express CYP2E1 which is upregulated by
ethanol [38]. Preliminary work showed that the gene expression of CYP2e1 in mouse kidney
cortex is only about 12.5% of that in the liver. CYP2e1 expression in glomerular cells has
not been described. We found that untreated mouse podocytes do not express CYP2e1 while
a high concentration of ethanol (0.4 mmol/mL) induced CYP2e1 expression (Figure 3D).
As anticipated, induction of CYP2e1 gene expression was associated with increased
superoxide production in podocytes treated with ethanol (0.4 mmol/mL, Figure 3D)
indicating oxidative stress. Oxidative stress is a major mechanism of ethanol toxicity in
humans [38]. Ethanol induces oxidative stress in neurons [39] and hepatocytes [40] and
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alters the oxidation state and antioxidant defense system in the kidney [41]. These effects
may depend on the dose [42] and chronicity of exposure [43–46], and on the nature of the
beverage [47].
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A dose-dependent derangement of the actin cytoskeleton at ethanol concentrations 0.1–0.4
mmol/mL (Figures 1 and 3) suggests that oxidative stress is associated with the disruption of
cytoskeletal integrity. However, cytoskeletal changes in podocytes [48, 49, 50], neurons
[51], hepatic cells [52] and pancreatic acini [53] vary and appear to be cell-type dependent
[54]. Oxidative stress-induced structural changes involve altered intracellular signaling [55].
Ethanol influences multiple signaling pathways and alters the expression of a number of
genes. We selected ERK and Akt phosphorylation as examples of the potential link between
increased superoxide production, signaling events and cellular changes observed. Ethanol
alters MAPK signaling directly or through its metabolites and oxidative stress. Changes in
MAPK and Akt signaling with derangement of the actin cytoskeleton in podocyte and
mesangial cells have been linked to superoxide production/oxidative stress [56, 57].
Transient upregulation of p38 MAPK phosphorylation with actin cytoskeleton
reorganization in podocytes was observed in oxidative stress-mediated nephropathy induced
by adriamycin or puromycin [58]. We found that ethanol upregulated both ERK1/2 and Akt
phosphorylation (Figures 5C–5F). Increased Akt phosphorylation inactivates GSK-3β and
prevents mitochondrial permeability transition pore (mPTP) opening [59]. While Akt/NRF2dependent mechanism mediates the cardioprotection provided by moderate amounts of
ethanol [60], detrimental role of Akt associated with oxidative stress in specific pathological
conditions (e.g., myocardial infarction or severe dyslipidemia) is also known [61]. Thus,
high amounts of ethanol induce oxidative stress and may alter podocyte structure through
changes in MAPK and Akt signaling pathways.
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The finding that ethanol at low concentrations upregulates ADH expression that is
attenuated at high concentrations (Figures 5A, 5B) suggests that cellular response to
metabolize ethanol through the ADH reaction reaches a peak at low to moderate
concentrations of ethanol while CYP2e1 is not induced at these concentrations. We
speculate that the potential beneficial effects of ethanol are likely only in the narrow range
of concentrations where ethanol is metabolized by the ADH reaction without induction and
action of CYP2e1.
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The dual effect of ethanol on ADH protein expression suggests that ethanol regulates its
own metabolism in podocytes. Also, ADH expression at basal conditions indicated the
possibility of additional substrates for ADH isoenzymes. ADH class IV is known to oxidize
retinol and omega-hydroxy fatty acids [15-18]. ADH activity converts omega hydroxyl
group of 20-HETE into its dicarboxylic acid form 20-COOH-AA in coronary endothelial,
renal epithelial, endothelial and smooth muscle cells [16]. Notably, 20-COOH-AA is more
stable than 20-HETE and functions as a ligand of peroxisome proliferator-activated
receptors-α and γ (PPAR-α, PPAR-γ), nuclear receptor proteins that function as
transcription factors for mediating the effects of eicosanoids including 20-HETE.
Additionally, 20-COOH-AA causes vasorelaxation in endothelin-constricted microvessels
whereas 20-HETE shows no effect [10, 16].
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LC-MS analysis showed that 20-HETE is present in untreated podocytes but the role of this
abundant eicosanoid in the glomerular filtration barrier is not known. It is possible that ADH
converts 20-HETE into 20-COOH-AA in podocytes under physiological conditions. We
found a significant increase in CYP4a12a gene expression by 8 hr of incubation with lower
concentrations of ethanol (0.02–0.1 mmol/mL) followed by a significant decrease by 24 hr
in the 0.4 mmol/mL group (Figure 4). While detailed analyses of enzyme expression and
activity remain to be determined, we have shown that 20-HETE preserves and protects the
glomerular filtration barrier function indicated by its blocking effect on PAN-induced
increase in Palb [9]. Presently, a significant increase in Palb (Figure 6A) at high concentration
of ethanol (0.4mmol/mL) suggests direct glomerular injury that parallels changes observed
in cultured podocytes. Inhibition of ADH in isolated glomeruli resulted in increased Palb
(Figure 7A) suggesting a role for ADH in glomerular function under physiological
conditions. We also found that 20-HETE and 20-COOH-AA each blocked the effect of the
ADH inhibitor fomepizole (Figure 7B). Thus, comparable protective effect of 20-HETE and
20-COOH-AA suggests that 20-COOH-AA may be the functional mediator of 20-HETE in
maintaining the glomerular filtration barrier.
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In summary, our results show that ethanol at high concentration causes podocyte actin
cytoskeleton derangement, increased production of superoxide, upregulation of pAkt and
pERK1/2, downregulation of CYP4a12a and ADH and increased glomerular albumin
permeability. In contrast, ethanol at low concentrations upregulates ADH protein and
CYP4a12a omega hydroxylase gene expression. Active ADH appears to be required to
maintain the glomerular permeability barrier. The ADH metabolite of 20-HETE, 20-COOHAA, may be the intracellular mediator of ADH-catalyzed preservation and protection of the
glomerular barrier function. We hypothesize that benefit or harm of alcohol consumption in
humans may include changes in podocyte structure and function particularly by altering
eicosanoid metabolism.
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•

Ethanol consumption at low quantities appears to have beneficial effect on
chronic kidney disease, proteinuria and cardiovascular function. However, the
effect of ethanol on the kidney or glomerular podocytes has not been reported.

•

Podocytes express alcohol dehydrogenase (ADH) that metabolizes alcohol at the
hydroxyl group. Podocytes produce 20-HETE by omega hydroxylation of
arachidonic acid (AA) by cytochrome P450 hydroxylase (CYP450 hydroxylase)
and do not express superoxide forming CYP450 2e1.

•

Ethanol at high concentrations inhibits ADH and CYP450 omega hydroxylase,
induces CYP450 2e1 and increases superoxide production in podocytes. Ethanol
at high concentrations increases glomerular albumin permeability. ADH
inhibitor fomepizole increases glomerular protein permeability, an effect
blocked by 20-HETE or its metabolite 20-COOH-AA generated by ADH
activity. Thus, ADH and CYP450 hydroxylase activities are required for
maintaining podocyte integrity and glomerular barrier function.

•

Ethanol at relevant low concentrations maintains podocyte actin cytoskeleton
and, upregulates CYP450 omega hydroxylase and ADH. Small quantities of
alcohol appear to protect glomerular protein filtration function.
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FIGURE 1. Ethanol at high concentrations causes derangement of the actin cytoskeleton in
podocytes

Differentiated podocytes were incubated with ethanol (0.02–0.4 mmol/mL) for 8 hr. Cells
were stained for actin filaments using phalloidin and observed using confocal microscope.
Representative images (63x objective) show that lower amounts of ethanol 0.04–0.1
mmol/mL did not alter the actin filament arrangement. A parallel arrangement of thick
bundles running across the cell was maintained. Higher concentration of ethanol (0.2–0.4
mmol/mL) caused visible change in the thickness, length and arrangement of actin
filaments. These changes were visible at 0.02 mmol/mL ethanol and a cortical ring like
structure was observed at 0.4 mmol/mL ethanol. Pre-treatment of cells with 100 nm 2-HETE
for 15 minutes before incubation with 0.4 mmol/mL ethanol prevented the cytoskeletal
derangement.
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FIGURE 2. Ethanol causes dose- and time-dependent apoptotic changes in podocytes
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Control and ethanol-treated (0.2 or 0.4 mmol/mL) podocytes were stained using annexin VFITC (x axis) and propidium iodide (y axis) at 6 and 24 hr and analyzed using flow
cytometry. Data are presented as four quadrant distribution dot plots - Upper Left (UL),
Upper Right (UR), Lower Left (LL) and Lower Right (LR). Combined data for late
apoptosis and necrosis are presented (Late Apoptosis+Necrosis). Bar graphs summarize
these observations at 6 and 24 hr that suggest increase in the number of apoptotic cells by
0.2 mmol/mL ethanol.
Normal cells (LL): At 6 hr, normal cells were comparable in all groups (70–80% of total cell
count). At 24 hr, Ethanol-treated groups showed 20% decrease compared to the control.
Early Apoptosis (LR): Early apoptotic cells count was 79% (6h) and 16% (24h) higher than
the time matched control in the 0.2 mmol/mL ethanol group. Cells showing early apoptosis
in the ethanol-treated group (0.4 mmol/mL) were 13% (6h) higher and 25% (24h) lower than
the control.
Late Apoptosis+Necrosis (UL+UR): Ethanol 0.2 mmol/mL caused a decline in the number
of these cells at 6 hr but a 29% increase over control by 24 hr. The 0.4 mmol/mL ethanoltreated group showed 23% (24h) higher number of cells with late apoptosis+necrosis
compared to the control group. Values represent average of two separate experiments.
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FIGURE 3. Ethanol increases superoxide generation in podocytes
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A. Immortalized podocytes were incubated with ethanol 0.2 or 0.4 mmol/mL.
Dihydroethidium (15 μM) was used to detect superoxide. Significant increase in
fluorescence due to ethanol (0.2 or 0.4 mmol/mL) was detectable at 1, 4 and 24 hr compared
to control. Fluorescence caused by 0.4 mmol/mL was significantly greater than that by 0.2
mmol/mL ethanol only at 1 hr (P<0.05, n=20 cells in two separate experiments). Ethanol at
0.2 and 0.4 mmol/mL caused significant increase in superoxide production at 1, 4 and 24 hr
compared to the their respective control groups (*, P<0.05)
B. Pre-treatment of cells with 100 nM 20-HETE blocked the effect of 0.2 mmol/mL ethanol
on superoxide production at 4 hr (P<0.001 vs. ethanol treated group).
C. Pre-treatment of cells with 100 nM 20-HETE blocked the effect of 0.4 mmol/mL ethanol
on superoxide production at 4 hr (P<0.001 vs. ethanol treated group).
D. Total RNA was prepared from untreated control and ethanol-treated podocytes (0.2 or 0.4
mmol/mL, 4 hr) and analyzed using RT-qPCR. CYP2e1 gene expression was significantly
increased in podocytes treated with 0.4 mmol/mL (P<0.001 vs control). (n=4/group, each
value represents average of 3 determinations).
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FIGURE 4. Ethanol at high concentrations downregulates CYP4a12a gene expression
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Differentiated podocytes were treated with 0.02–0.4 mmol/mL ethanol for 1, 8 and 24 hr.
Numbers 1–5 indicate treatment groups in the bar graph. Thus, 1= 0.02; 2=0.04; 3=0.1;
4=0.2 and 5=0.4 mmol ethanol/mL. Total RNA was analyzed for CYP4a12a expression as
described. GAPDH was used as the housekeeping gene control. Data calculated as ΔΔCt
were normalized with GAPDH gene expression and average fold-change values of 4
replicate experiments are presented. Ethanol at 0.02, 0.04, 0.1 and 0.2 mmol/mL caused
significant increase in CYP4a12a at 8 hr. Ethanol at 0.4 mmol/mL caused a significant
decrease in CYP4a12a gene expression. (*, P<0.05 vs. control n=4 replicate experiments
each analyzed in triplicates)
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FIGURE 5. Ethanol at high concentrations down regulates ADH protein expression and up
regulates Akt and ERK1/2 phosphorylation
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Podocytes were incubated with ethanol (0.02–0.4 mmol/mL) for 1 hr at 37°C.
Representative Western Blots and bar graphs of image intensity ratios (protein/β-actin
ratios) are shown (mean±SEM).
A and B. Ethanol-induced expression of total ADH in a dose-dependent manner that was
noticeable at 0.04 mmol/mL and significantly increased at 0.1 and 0.2 mmol/mL ethanol (*,
P<0.05, n=3) but not at 0.4 mmol/mL ethanol.
C and D. Ethanol dose-dependently upregulated phosphorylation of Akt between 0.1 and
0.4 mmol/mL concentrations (P<0.05, n=5). Levels of total Akt protein expression remained
unchanged.
E and F. Ethanol dose-dependently upregulated phosphorylation of ERK 1/2 between 0.1
and 0.4 mmol/mL concentrations (P<0.05, n=5). Total ERK 1/2 protein expression did
change.
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FIGURE 6.
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Isolated rat glomeruli were incubated with (A) ethanol 0.02–0.4 mmol or with (B) 0.4
mmol/mL ethanol after pre-treatment with fomepizole (10 μM) for 15 minutes at 37°C. Palb
was determined using an in vitro video-microscopy assay.
A. Ethanol at 0.04 and 0.1 mmol/mL resulted in Palb lower than the control group (*,
P<0.001 and **, P<0.05 vs. control, respectively). Palb after incubation with ethanol 0.2
mmol/mL was not different from control. However, Palb after incubation with ethanol at 0.4
mmol/mL increased significantly (*, P<0.001 vs. control, n= 15 glomeruli, 3 rats, 5
glomeruli from 1 rat in each group).
B. Isolated glomeruli were incubated with ethanol alone, with fomepizole followed by
ethanol or with fomepizole alone. Experimental groups are indicated by numbers 1–5. (1)
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Ethanol 0.04 mmol/mL, (2) 15 minute pre-incubation with 10μM fomepizole followed by
addition of 0.04 mmol/mL ethanol and incubation for 15 minutes, (3) ethanol 0.1 mmol/mL,
15 minutes, (4) pre-incubation for 15 minutes with 10μM fomepizole followed by addition
of 0.1 mmol/mL ethanol and incubation for 15 minutes (5) 10μM fomepizole for 15 minutes.
Control glomeruli incubated in the medium for 15 minutes. Pre-treatment of glomeruli with
fomepizole (10μM) blocked the effect of ethanol 0.04 or 0.1 mmol/mL (*, P<0.001 vs.
ethanol alone groups) and increased Palb that was comparable to fomepizole alone (#,
P<0.001 vs. control, n= 15 glomeruli, 3 rats, 5 glomeruli from each rat).
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FIGURE 7. 20-HETE blocks fomepizole-induced increase in glomerular albumin permeability
(Palb)
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Isolated rat glomeruli were incubated with (A) fomepizole (2–10 μM) or with (B) 20-HETE
(0.1 μM) for 15 minutes at 37°C. Palb was determined using an in vitro video-microscopy
assay.
A. Fomepizole increased glomerular Palb at 2 μM (P<0.001) and showed incremental effect
with dose. n= 15 glomeruli, 3 rats (5 glomeruli from 1 rat) in each group, *, P<0.001 vs.
fomepizole 2, 5 or 10 μM.
B. Pre-treatment with 20-HETE (0.1 μM) for 15 minutes before adding fomepizole blocked
the increase in Palb caused by fomepizole. However, adding 20-HETE 15 minute after
fomepizole did not block the increase in Palb. n= 15 glomeruli, 3 rats (5 glomeruli from 1
rat) in each group, *, P<0.001 vs. fomepizole alone.
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FIGURE 8. 20-HETE and its metabolite 20-COOH-arachidonic acid block the effect of FSGS
factor or PAN on glomerular albumin permeability

Isolated rat glomeruli were incubated with 20-HETE (0.1 μM), 20-COOH-AA (0.1, 1 μM)
followed by FSGS serum (20μL/mL) or by PAN (20 μg/mL) and incubated for 15 minutes.
Change in Palb was determined using an in vitro assay. 20-HETE or 20-COOH-AA did not
alter glomerular permeability.
A. Schematic shows that 20-HETE is metabolized by ADH to form 20-COOH-AA that can
be blocked by ADH inhibitor fomepizole.
B. FSGS increased albumin permeability (P<0.001) and its effect was blocked by 20-HETE
(0.1 μM) or 20-COOH-AA (0.1 μM).
C. PAN increased albumin permeability (P<0.001). 20-HETE blocked the increase in
permeability at 0.1 μM and 20-COOH-AA at 1 μM. n= 15 glomeruli, 3 rats (5 glomeruli
from 1 rat) in each group, *, P<0.001.
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